Nurix Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 11/13/2025 | 8.89 M | $82.12 M | -14.89% | 10.56% |
| BLACKROCK, INC. | 11/12/2025 | 6.76 M | $62.49 M | -0.68% | 8.04% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 6.06 M | $55.97 M | -0.13% | 7.20% |
| VANGUARD GROUP INC | 11/07/2025 | 4.49 M | $41.48 M | 0.52% | 5.33% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 3.88 M | $35.87 M | 0.00% | 4.61% |
| COMMODORE CAPITAL LP | 11/14/2025 | 3.78 M | $34.93 M | -4.27% | 4.49% |
| REDMILE GROUP, LLC | 11/14/2025 | 3.68 M | $33.99 M | -1.46% | 4.37% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 3.48 M | $32.11 M | 73.75% | 4.13% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 2.87 M | $26.53 M | -22.47% | 3.41% |
| STATE STREET CORP | 11/14/2025 | 2.86 M | $26.45 M | 13.04% | 3.40% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 2.42 M | $22.39 M | 0.00% | 2.88% |
| MORGAN STANLEY | 11/14/2025 | 2.26 M | $20.89 M | 4.32% | 2.69% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2025 | 2.17 M | $20.04 M | 84.78% | 2.58% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.98 M | $18.30 M | -0.91% | 2.35% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.88 M | $17.40 M | 0.04% | 2.24% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 10/27/2025 | 1.56 M | $14.39 M | 11.92% | 1.85% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 11/12/2025 | 1.56 M | $14.39 M | 12.11% | 1.85% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.52 M | $14.08 M | 64.30% | 1.81% |
| ARK INVESTMENT MANAGEMENT LLC | 11/12/2025 | 1.51 M | $13.96 M | -4.10% | 1.79% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 1.44 M | $13.30 M | 290.06% | 1.71% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 1.42 M | $13.09 M | 29.09% | 1.68% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2025 | 1.20 M | $11.07 M | -51.60% | 1.42% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 1.10 M | $10.16 M | -63.77% | 1.31% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 967.62 K | $8.94 M | 0.00% | 1.15% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 864.38 K | $7.99 M | 42.37% | 1.03% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 716.54 K | $6.62 M | 100.86% | 0.85% |
| NORTHERN TRUST CORP | 11/14/2025 | 680.01 K | $6.28 M | 4.05% | 0.81% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 622.30 K | $5.75 M | 6.46% | 0.74% |
| CITADEL ADVISORS LLC | 11/14/2025 | 565.31 K | $5.22 M | -64.42% | 0.67% |
| ALGERT GLOBAL LLC | 11/14/2025 | 563.84 K | $5.21 M | 392.44% | 0.67% |
| HANDELSBANKEN FONDER AB | 11/12/2025 | 520.00 K | $4.81 M | 85.71% | 0.62% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 481.05 K | $4.44 M | 47.02% | 0.57% |
| PATIENT SQUARE CAPITAL LP | 11/10/2025 | 437.24 K | $4.04 M | 6.05% | 0.52% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 430.96 K | $3.98 M | 0.91% | 0.51% |
| UBS GROUP AG | 11/13/2025 | 362.55 K | $3.35 M | -77.18% | 0.43% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2025 | 350.00 K | $3.23 M | 12.90% | 0.42% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 11/13/2025 | 347.50 K | $3.21 M | 87.84% | 0.41% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2025 | 327.95 K | $3.03 M | 100.00% | 0.39% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2025 | 314.76 K | $2.91 M | 0.00% | 0.37% |
| WASATCH ADVISORS LP | 11/14/2025 | 313.89 K | $2.90 M | -35.54% | 0.37% |
| BESSEMER GROUP INC | 11/05/2025 | 306.00 K | $2.83 M | 0.00% | 0.36% |
| CANDRIAM S.C.A. | 11/06/2025 | 262.38 K | $2.42 M | 0.00% | 0.31% |
| JANE STREET GROUP, LLC | 11/14/2025 | 258.65 K | $2.39 M | 100.00% | 0.31% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 255.79 K | $2.36 M | -82.54% | 0.30% |
| MARSHALL WACE, LLP | 11/13/2025 | 246.79 K | $2.28 M | 100.00% | 0.29% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/13/2025 | 246.74 K | $2.28 M | -4.29% | 0.29% |
| BARCLAYS PLC | 11/12/2025 | 245.10 K | $2.26 M | -3.84% | 0.29% |
| ENSIGN PEAK ADVISORS, INC | 11/13/2025 | 230.83 K | $2.13 M | 0.00% | 0.27% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 228.76 K | $2.11 M | 2.07% | 0.27% |
| WESTHILL FINANCIAL ADVISORS, INC. | 10/14/2025 | 228.33 K | $2.11 M | 0.00% | 0.27% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Nurix Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 221 institutional investors and hedge funds held shares of Nurix Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 8.89 M
BlackRock, Inc.: 6.76 M
Deep Track Capital, LP: 6.06 M
VANGUARD GROUP INC: 4.49 M
BAKER BROS. ADVISORS LP: 3.88 M
COMMODORE CAPITAL LP: 3.78 M
100.73% of Nurix Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 101.76 M shares in the last 24 months. This purchase volume represents approximately $954.51 M in transactions.